InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score32
United States Fiscal year ends December CIK 0001671858
$4.23 -7.24% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.23 −54.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−32.9Net income−32.9Fiscal year 2021Revenue5.5Operating income−19.5Net income−20.2EPS, diluted−0.70Fiscal year 2022Revenue1.3 −76.1%Operating income−35.5Net income−34.7EPS, diluted−0.87Fiscal year 2023Revenue0.0 −97.7%Operating income−67.5Net income−54.4EPS, diluted−0.57Fiscal year 2024Revenue89.1 +297,063.3%Operating income−3.1Net income8.0EPS, diluted0.08Fiscal year 2025Revenue84.3 −5.5%Operating income−179.4Net income−171.3 −2,241.8%EPS, diluted−1.74
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 5.5 1.3 0.0 89.1 84.3
Growth −76.1% −97.7% +297,063.3% −5.5%
Operating income −32.9 −19.5 −35.5 −67.5 −3.1 −179.4
Net income −32.9 −20.2 −34.7 −54.4 8.0 −171.3
Growth −2,241.8%
EPS, diluted n/a −0.70 −0.87 −0.57 0.08 −1.74

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Operating margin−353.3%Net margin−367.7%Free cash flow margin−319.9%Fiscal year 2022Operating margin−2,698.8%Net margin−2,635.4%Free cash flow margin−3,060.6%Fiscal year 2023Operating margin−225,066.7%Net margin−181,216.7%Free cash flow margin−198,136.7%Fiscal year 2024Operating margin−3.5%Net margin9.0%Free cash flow margin14.6%Fiscal year 2025Operating margin−212.9%Net margin−203.3%Free cash flow margin−203.1%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −353.3% −2,698.8% −225,066.7% −3.5% −212.9%
Net margin n/a −367.7% −2,635.4% −181,216.7% 9.0% −203.3%
Free cash flow margin n/a −319.9% −3,060.6% −198,136.7% 14.6% −203.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−31.2Capital expenditure−0.9Free cash flow−32.1Fiscal year 2021Operating cash flow−17.6Capital expenditure−0.1Free cash flow−17.6Fiscal year 2022Operating cash flow−40.1Capital expenditure−0.2Free cash flow−40.3Fiscal year 2023Operating cash flow−59.3Capital expenditure−0.2Free cash flow−59.4Fiscal year 2024Operating cash flow13.5Capital expenditure−0.6Free cash flow13.0Fiscal year 2025Operating cash flow−170.9Capital expenditure−0.3Free cash flow−171.2 −1,418.5%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −31.2 −17.6 −40.1 −59.3 13.5 −170.9
Capital expenditure −0.9 −0.1 −0.2 −0.2 −0.6 −0.3
Free cash flow −32.1 −17.6 −40.3 −59.4 13.0 −171.2
Growth −1,418.5%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash386.6Shareholders’ equity−14.1Fiscal year 2021Cash60.1Shareholders’ equity−31.3Fiscal year 2022Cash210.5Shareholders’ equity272.9Fiscal year 2023Cash71.0Shareholders’ equity230.8Fiscal year 2024Cash50.8Total debt0.0Net cash (debt)50.8Shareholders’ equity256.8Debt to equity0.00Fiscal year 2025Cash41.3Total debt96.4Net cash (debt)−55.1Shareholders’ equity114.3Debt to equity0.84
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 386.6 60.1 210.5 71.0 50.8 41.3
Total debt n/a n/a n/a n/a 0.0 96.4
Net cash (debt) n/a n/a n/a n/a 50.8 −55.1
Shareholders’ equity −14.1 −31.3 272.9 230.8 256.8 114.3
Debt to equity n/a n/a n/a n/a 0.00 0.84

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 5.5 1.3 0.0 89.1 84.3
Growth −76.1% −97.7% +297,063.3% −5.5%
n/a n/a n/a 0.0 n/a n/a
24.6 20.3 18.4 20.3 19.6 13.2
8.3 4.7 0.6 47.3 71.7 230.1
−32.9 −19.5 −35.5 −67.5 −3.1 −179.4
Growth
n/a n/a n/a −54.4 8.3 −171.4
0.0 0.0 0.0 0.0 0.3 −0.1
−32.9 −20.2 −34.7 −54.4 8.0 −171.3
Growth −2,241.8%
Per share
n/a −0.70 −0.87 −0.57 0.08 −1.74
n/a −0.70 −0.87 −0.57 0.08 −1.74
Growth −2,275.0%
n/a 28.9 40.0 95.2 96.9 98.6
n/a 28.9 40.0 95.2 102.4 98.6
Growth +38.4% +138.3% +7.5% −3.7%

† The diluted share count jumps at 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 5 of 6 years on file.